Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ADT-1004

Catalog No. T210541 Copy Product Info
Purity: 99.04%
🥰Excellent
ADT-1004 is a potent inhibitor of the RAS signaling pathway. This product blocks key oncogenic signaling cascades, such as MAPK/ERK and PI3K/AKT, by interfering with the activation of RAS proteins (including K-RAS, H-RAS, and N-RAS) and their interactions with downstream effectors. ADT-1004 exhibits high inhibitory activity against various cancer cell lines harboring RAS mutations, effectively inducing cell cycle arrest and triggering apoptosis, thereby suppressing tumor cell proliferation and survival.

ADT-1004

Copy Product Info
🥰Excellent
Catalog No. T210541

ADT-1004 is a potent inhibitor of the RAS signaling pathway. This product blocks key oncogenic signaling cascades, such as MAPK/ERK and PI3K/AKT, by interfering with the activation of RAS proteins (including K-RAS, H-RAS, and N-RAS) and their interactions with downstream effectors. ADT-1004 exhibits high inhibitory activity against various cancer cell lines harboring RAS mutations, effectively inducing cell cycle arrest and triggering apoptosis, thereby suppressing tumor cell proliferation and survival.

ADT-1004
Cas No. 1945941-72-9
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
5 mg$323-In Stock
10 mg$522-In Stock
25 mg$971-In Stock
50 mg$1,550-In Stock
100 mg$2,490-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.04%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
ADT-1004 is a potent inhibitor of the RAS signaling pathway. This product blocks key oncogenic signaling cascades, such as MAPK/ERK and PI3K/AKT, by interfering with the activation of RAS proteins (including K-RAS, H-RAS, and N-RAS) and their interactions with downstream effectors. ADT-1004 exhibits high inhibitory activity against various cancer cell lines harboring RAS mutations, effectively inducing cell cycle arrest and triggering apoptosis, thereby suppressing tumor cell proliferation and survival.
Chemical Properties
Molecular Weight589.65
FormulaC33H36FN3O6
Cas No.1945941-72-9
SmilesC(=C/1\C=2C(C(CC(NCC3=CC=CO3)=O)=C1C)=CC(F)=CC2)\C4=CC(OC)=C(OC(NC5CCN(C)CC5)=O)C(OC)=C4
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 3 mg/mL (5.09 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6959 mL8.4796 mL16.9592 mL84.7961 mL
5 mM0.3392 mL1.6959 mL3.3918 mL16.9592 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ADT-1004 | purchase ADT-1004 | ADT-1004 cost | order ADT-1004 | ADT-1004 chemical structure | ADT-1004 formula | ADT-1004 molecular weight